1Treatment strategy for hepatitis B and C Attach importance to cognitive education about hepatitis and increase obedience in interferon treatmentCHEN Xin-yueSYMPOSIUM819-821
2Treatment strategy for increasing the seroconversion rate in patients with HBeAg positive hepatitis BZHU Yue-yong, JIANG Jia-jiSYMPOSIUM821-823
3How to increase persistant response rate in patients with HBeAg negative hepatitis BZHAO Hong, WANG Gui-qiangSYMPOSIUM823-826
4Management of patients with hepatitis C before and after liver transplantationCHEN Cheng-weiSYMPOSIUM826-828
6Extrahepatic autoimmunization in hepatitis C patients and its treatmentWANG Jiang-binSYMPOSIUM830-833
7Treatment strategy for increasing effectiveness on refractory hepatitis CSHI Guang-fengSYMPOSIUM833-835
8Endoscopic therapy for common bile duct calculiZHANG Shu-tian, WANG Yong-junEXPERT EXPERIENCE836-838,840
9Pathogenesis of drug-induced pancreatitis and its diagnosis and treatmentWANG Xing-peng, LI LeiEXPERT EXPERIENCE839-840
10Prevention and treatment for gastrointestinal damage caused by nonsteroidal anti-inflammatory drugsCHEN Min-hu, MAO WeiEXPERT EXPERIENCE841-843
11The main points of the British Guidelines for Chronic Kidney Disease and its comprehensionTANG Zheng, CHENG ZhenREVIEW OF THE GUIDELINES FOR DIAGNOSIS AND TREATMENT844-846
12The correlation of HIV viral load to percentage of CD38, HLA-DR expresson on CD8+ T lymphocyte in HIV/AIDS patientsORIGINAL CONTRIBUTIONS847-850
13Comparison of fludarabine plus mitoxantrone combination therapy with CHOP for malignant lymphomaORIGINAL CONTRIBUTIONS851-852
15Expression of COX-2 in gastric cancer and gastritis and its relationship with HPORIGINAL CONTRIBUTIONS857-859
16Evaluation of inflammation and oxidative stress in uremic patients on peritoneal dialysis (PD)with different peritoneal transport statusORIGINAL CONTRIBUTIONS860-862
17Total lymphocyte count as a surrogate for CD4+ T lymphocyte count in Chinese HIV-1 infected peopleORIGINAL CONTRIBUTIONS867-869
18The empirical study of the effect of blocking the JAK-STAT signal pathway in the treatment of rat's rheumatoid arthritisORIGINAL CONTRIBUTIONS872-875
